Gujarat Fluorochemicals Limited (FLUOROCHEM) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated August 08, 2026 3 min read

Gujarat Fluorochemicals is a leading Indian chemical manufacturer pivoting toward high-growth segments like fluoropolymers and battery materials. This quarter, investors are focused on the operational ramp-up of its new R-32 refrigerant capacity and the scaling of its battery materials vertical following recent capital investments.

Quick Details

Results date	August 12, 2026
Quarter	Q1 FY 2026-2027
Previous quarter revenue	Rs. 1,369 Cr
Previous quarter PAT	Rs. 112 Cr
Previous quarter EBITDA margin	22%
Net debt (latest quarter)	Rs. 1,849 Cr
Market cap	Rs. 49,631.33 Cr
CMP	Rs. 4,518.1

Gujarat Fluorochemicals Limited Q1 Results Date and Time

The board meeting to consider and approve unaudited standalone and consolidated results for Q1 FY27 is scheduled for August 12, 2026.

The company has intimated a conference call with analysts and institutional investors on August 12, 2026, at 17:00 IST, led by Dr. Bir Kapoor (CEO & DMD).

What to expect from Gujarat Fluorochemicals Limited's Q1 FY27 results

Revenue is expected to show growth YoY, supported by the first full quarter of 10,000 tpa R-32 capacity and the positive impact of US tariff reductions on fluoropolymer realizations. While the chemical segment benefits from semiconductor-driven demand for high-performance fluoropolymers, battery materials segment losses may remain elevated as the company absorbs gestation costs from the LiPF6 plant capitalized in January 2026. Management's commentary will be critical in assessing the progress toward the high 3-digit annualized revenue exit rate targeted for the battery materials vertical by Q4 FY27. The upcoming call will likely address the pacing of the Rs. 800 Cr core capex and Rs. 2,300 Cr EV-related investment planned for FY27.

Key Things To Watch

Battery materials commercial ramp: Monitoring the transition from plant stabilization to revenue contribution.

LiPF6 commercial sales ongoing with repeat orders received in Q4 FY26.
PVDF binder commercial revenue expected by Q2 FY27.
LFP CAM final qualification milestone targeted for Q3 FY27.

Refrigerant segment performance: Evaluating the impact of new capacity on revenue mix.

First full quarter of 10,000 tpa R-32 capacity operational since April 2026.
Strategic intent announced June 29, 2026, to expand R134A capacity.
Management outlook on R-22 quota constraints and R-125 price stability.

Working capital and US market recovery: Assessing the impact of trade policy changes on inventory levels.

Inventory days target of 170–180 days versus 201 days in Q3 FY26.
Volume recovery expectations following the reduction of US tariffs from 50% to 18%.

Composite scheme and corporate structure: Tracking the timeline for restructuring activities.

Composite scheme of arrangement received BSE and NSE NOCs on July 9, 2026.
Scheme to be filed with NCLT within six months of the NOC date.

Frequently Asked Questions

How is the company managing its battery materials capex?

The company has raised or tied up approximately Rs. 3,730 Cr, including Rs. 430 Cr from the IFC and Rs. 1,200 Cr from Middle Eastern sovereign funds. Total cumulative capex for the battery materials segment is planned at Rs. 6,000 Cr over 4–5 years.

What is the status of the R-32 refrigerant capacity expansion?

The first phase of 10,000 tonnes of R-32 capacity became operational in April 2026. The company is currently scaling this toward an overall target of 20,000 tonnes.

Is the company's revenue growing?

Consolidated revenue was Rs. 1,369 Cr in Q4 FY26, up from Rs. 1,136 Cr in Q3 FY26. Growth is supported by strong demand in high-performance fluoropolymers and the commencement of commercial supplies for LiPF6.